An expert oncologist and pathologist discuss molecular testing in metastatic colorectal cancer and the current and upcoming options for HER2-targeted therapies.
EP. 1: Overview of Molecular Testing in Colorectal Cancer
Jaclyn Hechtman, MD, provides an overview of the history of molecular testing in colorectal cancer and how testing has evolved.
EP. 2: Molecular Testing Options in Colorectal Cancer
A pathologist explains how she chooses between a variety of molecular testing technology options in colorectal cancer.
EP. 3: Detecting HER2 Amplification in Colorectal Cancer
Experts describe which patients should be screened for HER2 amplification in colorectal cancer and how best to detect it.
EP. 4: Challenges and Barriers to Colorectal Cancer Molecular Testing
Drs Hechtman and Cercek discuss how practice setting affects molecular testing options and the barriers patients face in receiving testing.
EP. 5: The Future of Molecular Testing in Colorectal Cancer
A look at how the molecular testing landscape in colorectal cancer is evolving.
EP. 6: Individualizing Therapy in HER2+ Metastatic Colorectal Cancer
Dr Jaclyn Hechtman presents the profile of a patient with HER2+ metastatic colorectal cancer and has a conversation with Dr Andrea Cercek on how to personalize frontline therapy selection in each patient.
EP. 7: Treatment Options after Disease Progression in Metastatic Colorectal Cancer
Andrea Cercek, MD, explains the potential treatment options for metastatic colorectal cancer after disease progression.
EP. 8: Novel Therapies in HER2-Amplified Metastatic Colorectal Cancer
Dr Andrea Cercek reviews key clinical trials in HER2-amplified colorectal cancer treatment and considers how the approval of new therapies will impact the current treatment landscape.
EP. 9: Advice for Providers Treating Metastatic Colorectal Cancer
Experts provide advice for providers treating patients with metastatic colorectal cancer and highlight exciting potential combination treatments on the horizon.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512